Prof. Dr. Jerzy Adamski Visiting Professor at UL MF

We are pleased that Prof. Dr. Jerzy Adamski decided to join us for the second year in a row as a Visiting Scientist / Professor (Scientific Advisor) at the University of Ljubljana, Faculty of Medicine, in the program group Functional Genomics and Biotechnology for Health, and in the Laboratory for Molecular Basis and Biomarkers of Hormone-Dependent Diseases at the Institute of Biochemistry and Molecular Genetics.

Prof. Dr. Jerzy Adamski is a world renowned medicinal scientists and expert in molecular endocrinology and high throughput metabolomics. He acts as an Editor-in-Chief for The Journal of Steroid Biochemistry and Molecular Biology (IF 4.292), a president and founder of German Society for Metabolomic Research and a co-founder and Chief Scientific Officer for the biotech company Metaron Diagnostics i.G. He served as the head of Research Unit Molecular Endocrinology and Metabolism (MEM) at the Helmholtz Zentrum München in Neuherberg, Germany, and is currently Visiting Professor at the Yong Loo Lin School of Medicine, National University of Singapore, Singapore. We are honored that he accepted invitation to join as the Visiting Scientist / Professor to the University of Ljubljana, Faculty of Medicine. 

Prof. Dr. Adamski has been working for 20 years in the field of endocrine-related diseases and other common human diseases. He published 448 papers (e.g. Nature Genetics, 2010; Nature 2011 and 2020; Nature Reviews in Nephrology, 2017; Cell, 2018 and 2021)  holds several patents and has an H-index of 71. He developed prototypes for early diagnosis of endometriosis, diabetes type 2, kidney dysfunction and cardiovascular complications. Recently he edited and co-authored a book “Metabolomics for biomedical research” (ISBN ISBN: 978-0-12-812784-1) published in 2020. At Metaron Diagnostics, he implements validated assays for diagnostics of complex human diseases by metabolomics. His further interests lie in networking and team building for the efficient problem solutions in biomedical discovery and applications. Among others, Prof. Adamski contributed to building the BioEndoCar EU-funded consortium. Currently, he is coordinating all activities with regard to IP protection in the collaborative project between University of Ljubljana, Medizinische Universität Wien and Helmholtz Zentrum München, focusing on metabolomic biomarkers of endometriosis. Since he joined University of Ljubljana as a Visiting Scientist / Professor, he has published seven manuscripts with affiliation UL MF in journals with high IF and thus contributed to scientific excellence of the University of Ljubljana and the Faculty of Medicine. 


Prof. Dr. Jerzy Adamski (photo: Helmholtz Zentrum München)